30-day notice

Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices

tkelley on DSK3SPTVN1PROD with NOTICES

be available at http://ntp.niehs.nih.gov/
go/ivive-wksp-2016.
Meeting and Registration: This
workshop is open to the public, free of
charge, with attendance limited only by
the space available. Registration is
required to attend both the webinars
and the workshop. Those persons
attending the workshop should plan to
participate in all four webinars.
However, viewing the webinars does not
require attendance at the workshop.
Individuals who plan to attend the
workshop must register at http://
ntp.niehs.nih.gov/go/ivive-wksp-2016 by
February 5, 2016. Individuals who plan
to participate in the webinars must
register at http://ntp.niehs.nih.gov/go/
ivive-wksp-2016 two business days prior
to the webinar date to ensure access.
Please visit this Web page for the most
current information about the webinars
and workshop. For those who register,
information about how to access the
webinar will be emailed within two
business days of each webinar.
Individuals with disabilities who
need accommodation to participate in
these events should contact Dr.
Elizabeth Maull at phone: (919) 316–
4668 or email: [email protected].
TTY users should contact the Federal
TTY Relay Service at (800) 877–8339.
Requests should be made at least five
business days in advance of the event.
Visitor and security information for
those attending the workshop can be
found at http://www2.epa.gov/
aboutepa/about-epas-campus-researchtriangle-park-rtp-north-carolina.
Background Information on
NICEATM: NICEATM conducts data
analyses, workshops, independent
validation studies, and other activities
to assess new, revised, and alternative
test methods and strategies. NICEATM
also provides support for the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM). The ICCVAM Authorization
Act of 2000 (42 U.S.C. 285l–3) provides
authority for ICCVAM and NICEATM in
the development of alternative test
methods. Information about NICEATM
and ICCVAM is found at http://
ntp.niehs.nih.gov/go/niceatm and
http://ntp.niehs.nih.gov/go/iccvam,
respectively.
Dated: September 14, 2015.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2015–23386 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

18:47 Sep 17, 2015

Jkt 235001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Aging of the
Lung.
Date: October 20, 2015.
Time: 3:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Maurizio Grimaldi, MD,
Ph.D., Scientific Review Officer, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Room
2c218, Bethesda, MD 20892, 301–496–9374,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–23388 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; United States and
Global Human Influenza Surveillance
in At-Risk Settings (NIAID)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health, has submitted to the
Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information

SUMMARY:

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

56477

collection was previously published in
the Federal Register on April 9, 2015,
page 19090 and allowed 60-days for
public comment. One comment was
received. However, it was not applicable
to this data collection. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Institute of Allergy and Infectious
Diseases (NIAID), National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Dr. Diane Post, Program Officer,
Respiratory Diseases Branch, NIAID,
NIH, 5601 Fishers Lane, Bethesda, MD
or call non-toll-free number at 240–627–
3348 or email your request, including
your address to: [email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: United States
and Global Human Influenza
Surveillance in at-Risk Settings, 0925—
NEW, National Institute of Allergies and
Infectious Diseases (NIAID), National
Institutes of Health (NIH).
Need and Use of Information
Collection: These studies will identify
individuals with or at risk for influenza
through focused surveillance in at-risk
settings within the United States and
internationally, rapidly identify
circulating influenza strains to identify
those with pandemic potential and
create an invaluable bank of human
samples from influenza patients to
allow the characterization of the
determinants of influenza transmission
to and among humans, the immune
response to influenza, and the basis of
severe disease—critical knowledge gaps
impacting effectiveness of decisionmaking around patient care and

E:\FR\FM\18SEN1.SGM

18SEN1

56478

Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices

pandemic preparedness. These studies
will provide insight into viral and host
determinants that may be contributing
to the transmission of influenza,
immune response to influenza, and

severity of influenza and associated
morbidity and mortality.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total

estimated annualized burden hours for
the entire 3 year request are 17334.

ESTIMATED ANNUALIZED BURDEN HOURS
Estimates of hour burden
Type of respondents

Hospital/care setting patients

Human Animal-interface patients.

Household Surveillance patients.

Study Staff .............................

tkelley on DSK3SPTVN1PROD with NOTICES

Totals .............................

Form name

Number of
respondents

Frequency of
response

Informed Consent Form ...............................
Form 1a Screening and enrollment log (Attachment 3).
Form 2a Eligibility Checklist (Attachment 4)
Form 3a Subject Identification (Attachment
5).
Form 4a Demographic and Exposure Information (Attachment 6).
Form 5a Current Symptoms (Attachment 7)
Form 6a Medical History (Attachment 8) .....
Form 8a Follow Up Assessment (Attachment 10).
Informed Consent Form ...............................

1600
........................

1
1

10/60
10/60

267
267

........................
........................

1
1

10/60
10/60

267
267

........................

1

10/60

267

........................
........................
........................

1
1
4

10/60
10/60
10/60

267
267
1,067

900

1

10/60

150

Form 1a Screening and enrollment log (Attachment 3).
Form 2a Eligibility Checklist (Attachment 4)
Form 3a Subject Identification (Attachment
5).
Form 4a Demographic and Exposure Information (Attachment 6).
Form 5a Current Symptoms (Attachment 7)
Form 6a Medical History (Attachment 8) .....
Form 8a Follow Up Assessment (Attachment 10).
Informed Consent Form ...............................

........................

1

10/60

150

........................
........................

1
1

10/60
10/60

150
150

........................

1

10/60

150

........................
........................
........................

25
1
25

10/60
10/60
10/60

3,750
150
3,750

500

1

10/60

83

Form 1a Screening and enrollment log (Attachment 3).
Form 2a Eligibility Checklist (Attachment 4)
Form 3a Subject Identification (Attachment
5).
Form 4a Demographic and Exposure Information (Attachment 6).
Form 5a Current Symptoms (Attachment 7)
Form 6a Medical History (Attachment 8) .....
Form 8a Follow Up Assessment (Attachment 10).
Informed Consent Form ...............................
Form 7a Enrollment Specimen Collection
(Attachment 9).
Form 9a ED Chart Review (Attachment 11)
Form 10a Chart Review—Inpatient Hospitalization (Attachment 12).
Form 11a Subject Withdrawal Form (Attachment 13).
Form 12a Subject checklist (Attachment 14)
Form 13A Enrollment Report (Attachment
15).
Form 14A 10% Data accuracy report (Attachment 16).
Form 15A—QC Checklist (Attachment 17) ..

........................

1

10/60

83

........................
........................

1
1

10/60
10/60

83
83

........................

1

10/60

83

........................
........................
........................

6
1
6

10/60
10/60
10/60

500
83
500

5
........................

600
600

10/60
10/60

500
500

........................
........................

600
600

10/60
10/60

500
500

........................

600

10/60

500

........................
........................

600
600

10/60
10/60

500
500

........................

600

10/60

500

........................

600

10/60

500

.......................................................................

3,005

........................

........................

17,334

Dated: September 10, 2015.
Dione Washington,
Project Clearance Liaison, NIAID, NIH.
[FR Doc. 2015–23479 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

18:47 Sep 17, 2015

Jkt 235001

PO 00000

Frm 00042

Fmt 4703

Sfmt 9990

E:\FR\FM\18SEN1.SGM

18SEN1

Average time
per response

Annual hour
burden